---
document_datetime: 2024-08-29 09:35:27
document_pages: 8
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/skilarence-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: skilarence-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 5.2245757
conversion_datetime: 2025-12-15 02:08:03.570325
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Skilarence

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                                                                                                                                                                                      | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| II/0034              | Update of section 5.1 of the SmPC in order to update the long term efficacy and safety information based on the final results from study M-41008-41 (Dimeskin 1); this is a phase IV non-randomised, non-interventional, open label study in adult patients with moderate to severe chronic plaque psoriasis to further assess long-term (12 months) efficacy and safety of Skilarence in routine daily practice in Spain. | 25/07/2024                          |                                             | SmPC and PL                      | Maintenance of efficacy has been observed during long- term treatment with dimethyl fumarate-containing products. In the pharmacokinetic and clinical studies the systemic exposure, efficacy and safety of Skilarence were shown to be comparable to the active comparator containing dimethyl fumarate. Hence it is reasonable to expect the long-term efficacy of Skilarence to also be comparable to dimethyl fumarate-containing products. |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | In addition, the MAH took the opportunity to update the list of local representatives. C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data    |            |            |                                  | For more information, please refer to the Summary of Product Characteristics.                                                                                                                                                                                            |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/10647 /202303 | Periodic Safety Update EU Single assessment - dimethyl fumarate (psoriasis)                                                                                                                                 | 26/10/2023 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                        |
| II/0032             | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                               | 31/08/2023 | n/a        |                                  |                                                                                                                                                                                                                                                                          |
| N/0031              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                            | 22/09/2022 |            | Labelling and PL                 |                                                                                                                                                                                                                                                                          |
| R/0030              | Renewal of the marketing authorisation.                                                                                                                                                                     | 16/12/2021 | 21/02/2022 | SmPC, Annex II, Labelling and PL | Based on the review of data on quality, safety and efficacy, the CHMP considered that the benefit-risk balance of Skilarence in the approved indication remains favourable and therefore recommended the renewal of the marketing authorisation with unlimited validity. |
| PSUSA/10647 /202103 | Periodic Safety Update EU Single assessment - dimethyl fumarate (psoriasis)                                                                                                                                 | 28/10/2021 | n/a        |                                  | PRAC Recommendation - maintenance                                                                                                                                                                                                                                        |
| IAIN/0028/G         | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or | 17/05/2021 | 21/02/2022 | Annex II and PL                  |                                                                                                                                                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

|                     | manufacturer of a novel excipient B.II.c.1.c - Change in the specification parameters and/or limits of an excipient - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release                                                                                                                                                                    |            |            |                                  |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------|
| IB/0027             | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                                                      | 01/04/2021 | 21/02/2022 | SmPC, Annex II, Labelling and PL |                                   |
| N/0026              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                    | 25/01/2021 | 21/02/2022 | PL                               |                                   |
| PSUSA/10647 /202006 | Periodic Safety Update EU Single assessment - dimethyl fumarate (psoriasis)                                                                                                                                                                                                                                                                                                                                                                                                                                         | 14/01/2021 | n/a        |                                  | PRAC Recommendation - maintenance |
| IB/0025/G           | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.a.1.i - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - | 22/12/2020 | n/a        |                                  |                                   |

<div style=\"page-break-after: always\"></div>

| N/0024              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 30/11/2020   | 21/02/2022   | PL          |                                                                                                                                                                           |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0023/G           | This was an application for a group of variations. B.I.c.z - Container closure system of the AS - Other variation B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter) B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of | 29/10/2020   | n/a          |             |                                                                                                                                                                           |
| PSUSA/10647 /201912 | Periodic Safety Update EU Single assessment - dimethyl fumarate (psoriasis)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 23/07/2020   | 09/10/2020   | SmPC and PL | Please refer to Skilanrece EMEA/H/C/PSUSA/00010647/201912 EPAR: Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation |
| N/0021              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 13/05/2020   | 19/08/2020   | PL          |                                                                                                                                                                           |
| II/0019             | B.I.b.1.f - Change in the specification parameters and/or limits of an AS, starting                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | 17/04/2020   | n/a          |             |                                                                                                                                                                           |

<div style=\"page-break-after: always\"></div>

|                     | material/intermediate/reagent - Change outside the approved specifications limits range for the AS                                                                                                                                                                                                                                                                                                                                                        |            |            |                        |                                   |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| PSUSA/10647 /201906 | Periodic Safety Update EU Single assessment - dimethyl fumarate (psoriasis)                                                                                                                                                                                                                                                                                                                                                                               | 16/01/2020 | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0016/G           | This was an application for a group of variations. B.I.a.1.f - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - Changes to quality control testing arrangements for the AS -replacement or addition of a site where batch control/testing takes place B.I.b.1.z - Change in the specification parameters and/or limits of an AS, starting                                                                         | 07/10/2019 | n/a        |                        |                                   |
| IA/0017             | A.6 - Administrative change - Change in ATC Code/ATC Vet Code                                                                                                                                                                                                                                                                                                                                                                                             | 26/08/2019 | 19/08/2020 | SmPC                   |                                   |
| IB/0015/G           | This was an application for a group of variations. B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 26/07/2019 | 19/08/2020 | SmPC, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

| PSUSA/10647 /201812   | Periodic Safety Update EU Single assessment - dimethyl fumarate (psoriasis)                                                                                                                                                                                                                                                                                                                                                                                                                  | 11/07/2019   | n/a        |             | PRAC Recommendation - maintenance   |
|-----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|-------------------------------------|
| IA/0014/G             | This was an application for a group of variations. B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS B.I.a.4.c - Change to in-process tests or limits applied during the manufacture of the AS - Deletion of a non-significant in-process test                                                                                                                                                                                | 26/04/2019   | n/a        |             |                                     |
| II/0008/G             | This was an application for a group of variations. C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority | 28/03/2019   | 20/06/2019 | SmPC and PL |                                     |
| N/0012                | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                             | 06/03/2019   | 20/06/2019 | PL          |                                     |
| PSUSA/10647 /201806   | Periodic Safety Update EU Single assessment - dimethyl fumarate (psoriasis)                                                                                                                                                                                                                                                                                                                                                                                                                  | 17/01/2019   | n/a        |             | PRAC Recommendation - maintenance   |
| IB/0011               | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                                                                                                                               | 03/01/2019   | n/a        |             |                                     |

<div style=\"page-break-after: always\"></div>

| IB/0010/G           | This was an application for a group of variations. B.I.z - Quality change - Active substance - Other variation B.I.b.1.b - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.1.c - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Addition of a new specification parameter to the specification with its corresponding test method B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement   | 29/11/2018   | n/a        |                        |                                   |
|---------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-----------------------------------|
| PSUSA/10647 /201712 | Periodic Safety Update EU Single assessment - dimethyl fumarate (psoriasis)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 12/07/2018   | n/a        |                        | PRAC Recommendation - maintenance |
| IA/0007             | B.I.a.2.a - Changes in the manufacturing process of the AS - Minor change in the manufacturing process of the AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 28/06/2018   | n/a        |                        |                                   |
| IAIN/0006           | B.II.e.5.a.1 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change within the range of the currently approved pack sizes                                                                                                                                                                                                                                                                                                                                                                                                                                             | 20/06/2018   | 20/06/2019 | SmPC, Labelling and PL |                                   |

<div style=\"page-break-after: always\"></div>

| IA/0005   | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                                                                                        | 02/05/2018   | n/a   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|
| IB/0003   | B.II.b.3.z - Change in the manufacturing process of the finished or intermediate product - Other variation                                                                                                                                                                                                                 | 21/03/2018   | n/a   |
| IB/0002   | B.I.a.2.e - Changes in the manufacturing process of the AS - Minor change to the restricted part of an ASMF                                                                                                                                                                                                                | 09/01/2018   | n/a   |
| IA/0001/G | This was an application for a group of variations. B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure B.I.b.2.a - Change in test procedure for AS or starting material/reagent/intermediate - Minor changes to an approved test procedure | 23/11/2017   | n/a   |